#insulin4all USA
T1International Statement on Executive Orders
14 Sep 2020, 5:04 p.m. in #insulin4all USA, News & Statements by T1International
On Friday afternoon, President Trump released four executive orders intended to lower drug prices, including two targeted directly at lowering the cost of insulin for patients who rely on it. Despite his assertion that these orders are intended to “completely restructure the prescription drug market,” these orders will not do anything to fix the underlying cause of the insulin crisis in America. Patients will still need to wait months for the rulemaking process to run its course, and likely even longer after that if these orders end up in court. While T1International USA is glad that the administration has stated that making insulin more affordable is a priority, these orders miss the mark. We don’t need incremental bureaucratic steps as an election approaches - we need transformative change that will make our medicine more affordable now. Read more
T1International Statement on #insulin4all
21 Aug 2020, 4:17 p.m. in #insulin4all USA, News & Statements by T1International
T1International has been made aware of a recent increase in hateful speech, as well as disrespectful and non-collaborative behavior on the #insulin4all hashtag. While hashtags cannot be owned by anyone, T1International’s global work is tied to #insulin4all. As one of the creators of the hashtag, we want to acknowledge our concerns over these issues and set clear lines about what we stand for as an organization, and what we do not. Read more
Fighting for LGBTQ+ Justice and #insulin4all
8 Jul 2020, 10:17 p.m. in #insulin4all USA, Global Stories by Quinn Leighton
Delaying care due to these fears as a queer or trans person is not uncommon in any medical setting, however if you delay care living with diabetes, it can lead to life-threatening complications or even worse. It’s imperative that LGBTQ+ people living with diabetes and other chronic illnesses have the security, affirmation and resources to access the care they need. Read more
My Black Diabetic Life Matters
15 Jun 2020, 9:36 a.m. in #insulin4all USA, Global Stories by Anonymous
When I left the hospital I remember wondering, “Why did my mom have to beg those people to do their job when I was visibly sick?” A few years later after I had dealt with numerous visits, checkups, and insurance calls, I became aware of the medical side of racism. Read more
Utahns Welcome Passage of Insulin Access Amendments
27 May 2020, 1:18 p.m. in #insulin4all USA by Mindie Hooley
After many emotional months of fighting hard for accessible and affordable insulin legislation, Utah won a victory March 30, 2020 when House Bill 207, known as the Insulin Access Amendments, was signed into law by Governor Gary Herbert. This victory was thanks in part to the strong advocacy of thousands of Utahns and to Representative Norman Thurston’s dedicated leadership on drafting lifesaving legislation. This legislation passed with strong bipartisan support through the House with a 69-3 vote and passed unanimously in the Senate. Read more
Launch of U.S. State Legislative Guide for Insulin for All
14 May 2020, 10:41 a.m. in #insulin4all USA by T1International
T1International is pleased to introduce a new advocacy resource, the U.S. Legislative Guide for insulin for all: How States Can Make Medicines Affordable. The resource, developed in partnership with Public Citizen, outlines a variety of legislation that could help to make insulin more accessible and affordable. Read more
How Shareholders Benefit from Insulin Price Increases
6 May 2020, 11:11 a.m. in #insulin4all USA, Global Stories by Rosie Collington
In March of this year, researchers at the University of Pittsburgh provided evidence that the net price of insulin medicines in the United States had also soared – by 51% between 2008-2017. This indicates that while other intermediaries had benefited from list price increases, the manufacturers had too. This may seem obvious, but having data to prove it is important. Read more
Advocates Celebrate Passage of Alec Smith Bill in Minnesota
15 Apr 2020, 8:26 p.m. in #insulin4all USA by T1International
After months of diligent advocacy, partisan gridlock, and intense negotiations, the Alec Smith Emergency Insulin Bill was signed into law today in Minnesota. Alec’s Bill is named for 26-year-old Alec Smith, who passed away after rationing his insulin in 2017. The legislation, which is the first of its kind in the nation, establishes a program for patients with diabetes to purchase the insulin they need at an affordable price. To get to this moment, advocates in Minnesota endured a tough - and long - fight. Read more
T1International Statement on Insulin Manufacturer's Responses to COVID-19
7 Apr 2020, 5:29 p.m. in #insulin4all USA, News & Statements by T1International
The best way for insulin manufacturers to demonstrate their commitment to patient health would be for them to permanently lower their list price, which would make low-cost insulin easier to acquire and apply to every patient who needs it. Read more
Insulin Access Issues Affect People From All Walks of Life
16 Mar 2020, 10:22 a.m. in #insulin4all USA by Laura Nally, MD
In 1990, when I was 6 years old, I was diagnosed with insulin dependent type 1 diabetes. In 1996, I could purchase 1 vial of insulin for about $20 without insurance. Today, a vial of the same insulin that I have taken for 24 years costs somewhere between $250 and $400 in the United States1. There is no logical or scientific reason for this. To put things in perspective, in Canada, the same insulin costs about 1/10th of the price. Read more